Incyte
Price & Volume
Stats
See more52W Range | $50.34-$83.95 |
Market Cap | $11.7B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $4.2B |
Revenue Growth (YoY) | 16.3% |
Gross Profit (12 Mos) | $1.4B |
Diluted EPS | $0.15 |
News
See moreYahoo Finance • 14 days ago
Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico
Yahoo Finance • 14 days ago
Thérapeutique Knight annonce le lancement de Minjuvi® (tafasitamab) au Mexique
Yahoo Finance • 19 days ago
Why Incyte Stock Was Tanking This Week
Yahoo Finance • 23 days ago
Incyte stock dives after drug trial disappoints investors
About
CEO | Mr. Herve Hoppenot |
CFO | Ms. Christiana Stamoulis M.B.A. |
Address | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,617 |
